Newbridge Financial Services Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8K | Sell |
470
-3,955
| -89% | -$183K | ﹤0.01% | 702 |
|
|
2025
Q1 | $270K | Buy |
4,425
+3,422
| +341% | +$209K | 0.07% | 166 |
|
|
2024
Q4 | $56.7K | Buy |
+1,003
| New | +$56.7K | 0.01% | 376 |
|
|
2024
Q3 | – | Sell |
-1,875
| Closed | -$77.9K | – | 712 |
|
|
2024
Q2 | $77.9K | Sell |
1,875
-35
| -2% | -$1.45K | 0.03% | 300 |
|
|
2024
Q1 | $104K | Buy |
1,910
+216
| +13% | +$11.7K | 0.05% | 285 |
|
|
2023
Q4 | $86.9K | Sell |
1,694
-937
| -36% | -$48.1K | 0.04% | 298 |
|
|
2023
Q3 | $153K | Sell |
2,631
-27
| -1% | -$1.57K | 0.08% | 227 |
|
|
2023
Q2 | $170K | Sell |
2,658
-126
| -5% | -$8.06K | 0.08% | 222 |
|
|
2023
Q1 | $193K | Sell |
2,784
-73
| -3% | -$5.06K | 0.1% | 198 |
|
|
2022
Q4 | $206K | Buy |
2,857
+1,195
| +72% | +$86K | 0.12% | 173 |
|
|
2022
Q3 | $118K | Buy |
1,662
+29
| +2% | +$2.06K | 0.07% | 270 |
|
|
2022
Q2 | $126K | Sell |
1,633
-106
| -6% | -$8.18K | 0.08% | 232 |
|
|
2022
Q1 | $127K | Buy |
1,739
+78
| +5% | +$5.7K | 0.06% | 267 |
|
|
2021
Q4 | $104K | Sell |
1,661
-22
| -1% | -$1.38K | 0.05% | 295 |
|
|
2021
Q3 | $100K | Sell |
1,683
-395
| -19% | -$23.5K | 0.06% | 267 |
|
|
2021
Q2 | $139K | Sell |
2,078
-148
| -7% | -$9.9K | 0.09% | 224 |
|
|
2021
Q1 | $141K | Sell |
2,226
-229
| -9% | -$14.5K | 0.1% | 205 |
|
|
2020
Q4 | $152K | Sell |
2,455
-194
| -7% | -$12K | 0.13% | 170 |
|
|
2020
Q3 | $160K | Buy |
+2,649
| New | +$160K | 0.16% | 132 |
|